Email not displaying properly? View email in your browser
Vertical-Talk Pharma   >  Precision Medicine
>  Severe Hypoglycemia
>  Prenatal Treatment
  Oct 2020   e-Newsletter Advertise | Editorial Calendar  
Entris ll Laboratory Balances
Latest e-book
Histogen and Amerimmune Enter into a Collaborative Develop...
SFJ Pharmaceuticals partner, Apellis, enters Strategic Collaboration...
Press Releases
Telstar's centre in the United Kingdom moves into new premises...
ENHERTU Granted Priority Review in the U.S. for Treatment of HER2...
30 - 31 Oct 2020
Pharmaceutical Formulations & Drug Delivery
01 - 03 Nov 2020
Annual Radiology Meeting
09 - 10 Nov 2020
European Pharma Congress 2020
>  Personalised Therapy
     The Perspectives of Agglomerates
Tin Wui Wong, Professor, Non-Destructive Biomedical and Pharmaceutical Research Centre, iPROMISE, UniversitiTeknologi MARA (UiTM)
Precision medicine is a healthcare customisation platform whereby the personalised perspective involves analysis of patient's health data to customise the required therapy. This article describes the recent progress in agglomerate design including those prepared from nanoparticles as the therapeutic carrier to meet the required personalised dosage regimen. Drugs can be formulated in the form of tablets, pellets, emulsion, cream...
Techno Trends
> Gvoke HypoPen First Autoinjector Discovered for Severe Hypoglycemia
> A Breakthrough Therapy Developed for Investigational Prenatal...
> Fujifilm Invests US$83m to Expand Biotechnologies Microbial Capacity...
> Emergent BioSolutions Invests US$75 million in New Manufacturing...
Research Insights
> Statistical analysis of 3D localisation microscopy images for...
> Stochastic ordering of complexoform protein assembly by genetic...
  Subscribe  |  e-Book Archives  | Advisory Board  
Follow Us Facebook Twitter linkedin - Owned by Ochre Media Pvt. Ltd.